7742 related articles for article (PubMed ID: 1923993)
21. Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states.
Kruithof EK; Gudinchet A; Bachmann F
Thromb Haemost; 1988 Feb; 59(1):7-12. PubMed ID: 3129809
[TBL] [Abstract][Full Text] [Related]
22. The dexamethasone-induced inhibitor of plasminogen activator in hepatoma cells is antigenically-related to an inhibitor produced by bovine aortic endothelial cells.
Loskutoff DJ; Roegner K; Erickson LA; Schleef RR; Huttenlocher A; Coleman PL; Gelehrter TD
Thromb Haemost; 1986 Feb; 55(1):8-11. PubMed ID: 3486492
[TBL] [Abstract][Full Text] [Related]
23. A molecular variant of plasminogen activator inhibitor of rat decidual tissue.
Tarachand U; Pawse AR
Biochem Mol Biol Int; 1995 Dec; 37(6):1037-45. PubMed ID: 8747533
[TBL] [Abstract][Full Text] [Related]
24. Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis.
Ohba K; Miyata Y; Kanda S; Koga S; Hayashi T; Kanetake H
J Urol; 2005 Aug; 174(2):461-5. PubMed ID: 16006865
[TBL] [Abstract][Full Text] [Related]
25. Production of plasminogen activator and plasminogen activator inhibitor by bovine lymphatic endothelial cells: modulation by TNF-alpha.
Laschinger CA; Johnston MG; Hay JB; Wasi S
Thromb Res; 1990 Aug; 59(3):567-79. PubMed ID: 2237828
[TBL] [Abstract][Full Text] [Related]
26. Poly-D-lysine dependent inactivation of tissue plasminogen activator by a class PAI-2 inhibitor (minactivin).
Leung KC; Byatt JA; Stephens RW
Thromb Res; 1987 Jun; 46(6):767-77. PubMed ID: 3114909
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the dexamethasone-induced inhibitor of plasminogen activator in HTC hepatoma cells.
Coleman PL; Patel PD; Cwikel BJ; Rafferty UM; Sznycer-Laszuk R; Gelehrter TD
J Biol Chem; 1986 Mar; 261(9):4352-7. PubMed ID: 2936742
[TBL] [Abstract][Full Text] [Related]
28. The primary plasminogen-activator inhibitors in endothelial cells, platelets, serum, and plasma are immunologically related.
Erickson LA; Hekman CM; Loskutoff DJ
Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8710-4. PubMed ID: 3936043
[TBL] [Abstract][Full Text] [Related]
29. [Hemostasiology. Antifibrinolytic mechanisms of the liver].
Jedrychowski A; Parbhoo SP; Hillenbrand P
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1139-42. PubMed ID: 417485
[No Abstract] [Full Text] [Related]
30. [Plasminogen activator inhibitors].
Swiatkowska M; Wilczyńska M; Cierniewski CS
Postepy Biochem; 1991; 37(3-4):139-45. PubMed ID: 1812471
[No Abstract] [Full Text] [Related]
31. [Differences in plasminogen activator species released from endothelial cells of different sites].
Nakashima Y
Nihon Ketsueki Gakkai Zasshi; 1988 Nov; 51(7):1214-8. PubMed ID: 3146851
[No Abstract] [Full Text] [Related]
32. Purification of epidermal plasminogen activator inhibitor.
Hibino T; Izaki S; Izaki M
FEBS Lett; 1986 Nov; 208(2):273-7. PubMed ID: 3096778
[TBL] [Abstract][Full Text] [Related]
33. Plasminogen activators: pharmacology and therapy.
Holden RW
Radiology; 1990 Mar; 174(3 Pt 2):993-1001. PubMed ID: 2137641
[TBL] [Abstract][Full Text] [Related]
34. Possibilities of intervention in intrinsic and extrinsic lysis programs.
Lowe GD
Ann N Y Acad Sci; 1992 Dec; 667():272-7. PubMed ID: 1309044
[No Abstract] [Full Text] [Related]
35. [Role of plasminogen activators in cancer dissemination. Clinical perspectives].
Alonso DF; Bal de Kier Joffé E
Medicina (B Aires); 1992; 52(3):252-6. PubMed ID: 1342692
[No Abstract] [Full Text] [Related]
36. Tumor necrosis factor stimulates urokinase-type plasminogen activator and inhibitor type 1 production in A549 lung carcinoma cells: treatment of monolayer and tridimensional cultures.
Dosne AM; Beaupain R; Samama M
Semin Thromb Hemost; 1991 Jul; 17(3):240-5. PubMed ID: 1796296
[No Abstract] [Full Text] [Related]
37. Purification of a plasminogen activator inhibitor indistinguishable from alpha1-antitrypsin and an urokinase inhibitor in pregnancy plasma.
Clemmensen I; Thorsen S; Müllertz S
Haemostasis; 1976; 5(4):218-30. PubMed ID: 826461
[TBL] [Abstract][Full Text] [Related]
38. Differential inhibition of two molecular forms of melanoma cell plasminogen activator by a placental inhibitor.
Lecander I; Roblin R; Astedt B
Br J Haematol; 1984 Jul; 57(3):407-12. PubMed ID: 6430331
[TBL] [Abstract][Full Text] [Related]
39. Mutational and immunochemical analysis of plasminogen activator inhibitor 1.
Shubeita HE; Cottey TL; Franke AE; Gerard RD
J Biol Chem; 1990 Oct; 265(30):18379-85. PubMed ID: 2120233
[TBL] [Abstract][Full Text] [Related]
40. Co-cultivation of tumorigenic mouse melanoma cells with cells of a non-tumorigenic subclone inhibits plasminogen activator expression by the melanoma cells.
Kyner D; Christman J; Acs G; Silagi S; Newcomb EW; Silverstein SC
J Cell Physiol; 1978 May; 95(2):159-67. PubMed ID: 206566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
